Literature DB >> 8924914

Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients.

S Shimada1, Y Nakajima, K Yamamoto, Y Sawada, T Iga.   

Abstract

The relationships between plasma drug concentration and antihypertensive effect of eight calcium channel antagonists (nicardipine, nifedipine, nilvadipine, benidipine, manidipine, barnidipine, nitrendipine and efonidipine) in Japanese essential hypertensive patients were analyzed. Based on the effect compartment model, we could explain the long duration of the pharmacological effect, and there was significant correlation (r = 0.876, p < 0.05) between estimated EC50 values and the dissociation constants (Kd) obtained from in vitro binding studies. We also developed the ion-channel binding model to understand the pharmacodynamics of long acting calcium antagonists. The model was also well fitted to antihypertensive effect data. A significant correlation between the apparent in vivo dissociation constants and in vitro Kd values was observed with a slope of 1.45 (r = 0.913), suggesting that the mechanism of long-lasting antihypertensive effect of newer developed calcium antagonists is due to their high binding affinity at ion-channel sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924914     DOI: 10.1248/bpb.19.430

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  17 in total

1.  Inotropic effect of digoxin in humans: mechanistic pharmacokinetic/pharmacodynamic model based on slow receptor binding.

Authors:  Michael Weiss; Wonku Kang
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 2.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors.

Authors:  Shashi B Bhatt; Anton Amann; Vladimir Nigrovic
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-03       Impact factor: 2.745

4.  Comparison of the rapidity of onset of the therapeutic effect between nateglinide and mitiglinide by PK/PD analysis in rats.

Authors:  Toshiyuki Takanohashi; Harumi Arisaka; Kazuyuki Ubukata; Masahiro Hayashi; Yasuhiko Yamada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-10-20       Impact factor: 2.441

5.  Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine.

Authors:  Yu Eun Sunwoo; Phuong Thi Thu Nguyen; Chin May Chien; Ji Young Ryu; Jihong Shon; Jae-Gook Shin
Journal:  Br J Clin Pharmacol       Date:  2019-01-30       Impact factor: 4.335

Review 6.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

7.  Quantitative PK-PD model-based translational pharmacology of a novel kappa opioid receptor antagonist between rats and humans.

Authors:  Cheng Chang; Wonkyung Byon; Yifeng Lu; Leslie K Jacobsen; Lori L Badura; Aarti Sawant-Basak; Emily Miller; Jing Liu; Sarah Grimwood; Ellen Q Wang; Tristan S Maurer
Journal:  AAPS J       Date:  2011-08-17       Impact factor: 4.009

8.  In vivo and ex vivo inhibition of spinal nerve ligation-induced ectopic activity by sodium channel blockers correlate to in vitro inhibition of NaV1.7 and clinical efficacy: a pharmacokinetic-pharmacodynamic translational approach.

Authors:  Ivana Kalezic; Lei Luo; Per-Eric Lund; Anders B Eriksson; Tjerk Bueters; Sandra A G Visser
Journal:  Pharm Res       Date:  2013-02-01       Impact factor: 4.200

Review 9.  Moving from basic toward systems pharmacodynamic models.

Authors:  William J Jusko
Journal:  J Pharm Sci       Date:  2013-05-16       Impact factor: 3.534

10.  A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Authors:  Akihiro Hisaka; Makiko Kusama; Yoshiyuki Ohno; Yuichi Sugiyama; Hiroshi Suzuki
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.